Oestrogen and inhibition of oxidation of low-density lipoproteins in postmenopausal women

The Lancet

Volumn 343, Issue 8892, 1994, Pages 269-270

  Sack, M N ^a   Rader, Dj ^b   Cannon, R O ^b  

^a GEORGETOWN UNIVERSITY HOSPITAL   (United States)

^b NATIONAL HEART LUNG AND BLOOD INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ESTRADIOL; LOW DENSITY LIPOPROTEIN;

ADULT; ARTICLE; ATHEROSCLEROSIS; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; FEMALE; HUMAN; INTRAARTERIAL DRUG ADMINISTRATION; POSTMENOPAUSE; PRIORITY JOURNAL; TRANSDERMAL DRUG ADMINISTRATION;

EID: 0027958761     PISSN: 01406736     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0140-6736(94)91117-7     Document Type: Article

References (9)

1. Cardiovascular mortality and noncontraceptive use of estrogen in women: results from the Lipid Research Clinics Progam Follow-up Study
2. Role of oxidized low density lipoprotein in atherogenesis
3. Estrogens inhibit copper and cell-mediated modification of low density lipoprotein
4. The inhibition of low-density lipoprotein oxidation by 17-β estradiol
5. The distribution and chemical composition of ultracentrifugally separated lipoproteins in human serum
6. Continuous monitoring of in vitro oxidation of human low density lipoprotein
7. Disorders of the ovary and female reproductive tract
8. Effect of 17 beta estradiol on aortic cholesterol content and metabolism in cholesterol-fed rabbits
9. Inhibition of coronary artery atherosclerosis by 17-beta estradiol in ovariectomized monkeys